1R15NS121784 Kim (PI) 12/01/21 - 11/30/24 NIH. Prevention of alpha-synuclein deSUMOylation as a Parkinson’s therapeutic target.
5T32GM144895 Harrington & Kim (PIs) 05/01/22 – 4/30/27 NIH-G-RISE. Diversifying Neuroscience through predoctoral training at an HBCU.
1R25GM122722 Kim & Harrington (PIs) 05/01/17 - 03/31/23 (NCE) NIH-RISE. A graduate training program to increase diversity in biomedical Science.
Private Fund Kim (PI) 02/01/19 - 12/31/22 AptaBio therapeutics Inc. Developing a novel antioxidant compound as a therapeutic for Parkinson’s disease.
Copyright © 2022 Kim Lab for Neurodegenerative and Senescence Research - All Rights Reserved.